PH30180A - Leustroducsin h its preparation and its therapeutic use - Google Patents

Leustroducsin h its preparation and its therapeutic use

Info

Publication number
PH30180A
PH30180A PH48120A PH48120A PH30180A PH 30180 A PH30180 A PH 30180A PH 48120 A PH48120 A PH 48120A PH 48120 A PH48120 A PH 48120A PH 30180 A PH30180 A PH 30180A
Authority
PH
Philippines
Prior art keywords
leustroducsin
preparation
therapeutic use
compound
leustroducsins
Prior art date
Application number
PH48120A
Other languages
English (en)
Inventor
Yukio Sugimura
Tomo-Yuki Shibata
Kazuhiko Tamaki
Shinwa Kurihara
Takafumi Kohama
Akio Shiraishi
Tomowo Kobayashi
Kazuhiko Sasagawa
Naomi Shimazaki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of PH30180A publication Critical patent/PH30180A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH48120A 1993-04-23 1994-04-20 Leustroducsin h its preparation and its therapeutic use PH30180A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9805893 1993-04-23

Publications (1)

Publication Number Publication Date
PH30180A true PH30180A (en) 1997-01-21

Family

ID=14209715

Family Applications (1)

Application Number Title Priority Date Filing Date
PH48120A PH30180A (en) 1993-04-23 1994-04-20 Leustroducsin h its preparation and its therapeutic use

Country Status (19)

Country Link
US (1) US5409912A (de)
EP (1) EP0622372B1 (de)
JP (1) JPH072886A (de)
CN (1) CN1050845C (de)
AT (1) ATE166058T1 (de)
AU (1) AU665488B2 (de)
CA (1) CA2121735A1 (de)
CZ (1) CZ286364B6 (de)
DE (1) DE69410159T2 (de)
DK (1) DK0622372T3 (de)
ES (1) ES2116528T3 (de)
FI (1) FI941850A (de)
HK (1) HK1007857A1 (de)
HU (1) HU220223B (de)
IL (1) IL109227A (de)
NO (1) NO303640B1 (de)
NZ (1) NZ260364A (de)
PH (1) PH30180A (de)
RU (1) RU2098422C1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014704A1 (fr) * 1995-10-17 1997-04-24 Suntory Limited Medicament contre la thrombopenie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2865302B2 (ja) * 1988-02-13 1999-03-08 サントリー株式会社 2―ピラノン誘導体及びその製造法並びにそれを含む抗菌剤
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses
JPH05213758A (ja) * 1992-02-06 1993-08-24 Sankyo Co Ltd 血小板増多剤

Also Published As

Publication number Publication date
CN1105027A (zh) 1995-07-12
CZ286364B6 (cs) 2000-03-15
IL109227A0 (en) 1994-07-31
EP0622372A1 (de) 1994-11-02
EP0622372B1 (de) 1998-05-13
US5409912A (en) 1995-04-25
NZ260364A (en) 1995-07-26
CN1050845C (zh) 2000-03-29
AU5932394A (en) 1994-10-27
NO303640B1 (no) 1998-08-10
NO941478L (no) 1994-10-24
DE69410159D1 (de) 1998-06-18
CZ96494A3 (en) 1994-11-16
NO941478D0 (no) 1994-04-22
ATE166058T1 (de) 1998-05-15
DK0622372T3 (da) 1999-02-15
AU665488B2 (en) 1996-01-04
HU9401159D0 (en) 1994-07-28
FI941850A (fi) 1994-10-24
FI941850A0 (fi) 1994-04-21
HK1007857A1 (en) 1999-04-23
RU2098422C1 (ru) 1997-12-10
HUT68015A (en) 1995-05-29
DE69410159T2 (de) 1999-01-28
HU220223B (hu) 2001-11-28
IL109227A (en) 1998-01-04
JPH072886A (ja) 1995-01-06
CA2121735A1 (en) 1994-10-24
ES2116528T3 (es) 1998-07-16

Similar Documents

Publication Publication Date Title
KR0156747B1 (en) Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
ZA95631B (en) Prolineamide derivatives
IN172553B (de)
AU1302388A (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides
AU2101592A (en) Piperidine derivatives
ZA941464B (en) Use of pregnane derivative
HU9400908D0 (en) Pharmaceutical compositions for treatng skin disorders
GR3007079T3 (de)
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
HK1007857A1 (en) New compound leustroducsin H its preparation and its therapeutic use
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
AU2101792A (en) Methanoanthracene D2 dopamine antagonists
AU2532692A (en) Method for treating hypertension
IL114866A0 (en) Process for the preparation of the (-)-n-methyl-n-Ú4-(4-phenyl-4-acetylaminopiperidin-1-yl-2-(3,4-dichlorophenyl) butyl¾ benzamide
TW275629B (de)